| Original language | English (US) |
|---|---|
| Pages (from-to) | 223-226 |
| Number of pages | 4 |
| Journal | Oncology (Williston Park, N.Y.) |
| Volume | 32 |
| Issue number | 5 |
| State | Published - May 15 2018 |
Fingerprint
Prostatic Neoplasms
Drug Therapy
abiraterone
ASJC Scopus subject areas
- Oncology
- Cancer Research
Cite this
Isaacsson Velho, P., & Eisenberger, M. (2018). Point: Chemotherapy vs Abiraterone for the Initial Management of Metastatic Prostate Cancer: The Case for Chemotherapy. Oncology (Williston Park, N.Y.), 32(5), 223-226.
Point : Chemotherapy vs Abiraterone for the Initial Management of Metastatic Prostate Cancer: The Case for Chemotherapy. / Isaacsson Velho, Pedro; Eisenberger, Mario.
In: Oncology (Williston Park, N.Y.), Vol. 32, No. 5, 15.05.2018, p. 223-226.Research output: Contribution to journal › Article
Isaacsson Velho, P & Eisenberger, M 2018, 'Point: Chemotherapy vs Abiraterone for the Initial Management of Metastatic Prostate Cancer: The Case for Chemotherapy', Oncology (Williston Park, N.Y.), vol. 32, no. 5, pp. 223-226.
Isaacsson Velho P, Eisenberger M. Point: Chemotherapy vs Abiraterone for the Initial Management of Metastatic Prostate Cancer: The Case for Chemotherapy. Oncology (Williston Park, N.Y.). 2018 May 15;32(5):223-226.
@article{cf2cbe411c234c828344bf4b0b3663e0,
title = "Point: Chemotherapy vs Abiraterone for the Initial Management of Metastatic Prostate Cancer: The Case for Chemotherapy",
author = "{Isaacsson Velho}, Pedro and Mario Eisenberger",
year = "2018",
month = "5",
day = "15",
language = "English (US)",
volume = "32",
pages = "223--226",
journal = "Oncology",
issn = "0890-9091",
publisher = "UBM Medica Healthcare Publications",
number = "5",
}
TY - JOUR
T1 - Point
T2 - Chemotherapy vs Abiraterone for the Initial Management of Metastatic Prostate Cancer: The Case for Chemotherapy
AU - Isaacsson Velho, Pedro
AU - Eisenberger, Mario
PY - 2018/5/15
Y1 - 2018/5/15
UR - http://www.scopus.com/inward/record.url?scp=85050686587&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85050686587&partnerID=8YFLogxK
M3 - Article
VL - 32
SP - 223
EP - 226
JO - Oncology
JF - Oncology
SN - 0890-9091
IS - 5
ER -